Category: Catalyst Journey
Catalyst Clinical Research Launches Expanded Global Oncology, Functional and Resourcing Services Wilmington, NC, 18 January 2021 – Evolved from over 15 years serving the biopharma industry, Catalyst Read Now 
Catalyst Concludes Acquisition of Acumen Healthcare Solutions Bolsters Database Expertise, Positions Proprietary ‘Flex’ for Future Growth Wilmington, NC, 18 November 2020 – Catalyst Read Now 
Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged Read Now 
Catalyst Hires VP, Oncology Drug Development to Accelerate Growth and Oncology Services Offerings Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and Read Now Catalyst Hires VP, Oncology Drug Development, to Accelerate Growth and Oncology Services Offerings Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and Read Now 
Catalyst Hires Chief Strategy Officer to Fuel Growth and Innovation Wilmington, NC, 13 May 2020 – Catalyst Clinical Research, a clinical development and global resourcing Read Now 
Selected Partner for Artelo Biosciences Deliver the Upcoming Phase 1B/2A Trial of their Synthetic Cannabinoid, ART27.13 Aptus Clinical has been Read Now 
Catalyst Acquired Triangle Biostatistics Durham, N.C. (5 March 2019) – Catalyst Clinical Research, LLC (“Catalyst”), a leading provider of Read Now 
Partnership with Cell and Gene Therapy Catapult Aptus Clinical and Cell and Gene Therapy Catapult announce their clinical service collaboration to support Read Now